Johnson Investment Counsel’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,930
Closed -$1.68M 626
2019
Q3
$1.68M Sell
16,930
-5,961
-26% -$566K 0.03% 213
2019
Q2
$2.12M Sell
22,891
-8,047
-26% -$764K 0.04% 191
2019
Q1
$2.92M Sell
30,938
-5,082
-14% -$444K 0.06% 170
2018
Q4
$2.31M Sell
36,020
-10,126
-22% -$747K 0.06% 178
2018
Q3
$4.13M Sell
46,146
-2,912
-6% -$257K 0.09% 138
2018
Q2
$3.9M Sell
49,058
-4,090
-8% -$340K 0.1% 136
2018
Q1
$4.74M Sell
53,148
-39,404
-43% -$3.78M 0.12% 116
2017
Q4
$9.66M Buy
92,552
+6,378
+7% +$720K 0.24% 82
2017
Q3
$12.6M Buy
86,174
+150
+0.2% +$20.4K 0.33% 73
2017
Q2
$11.2M Sell
86,024
-2,074
-2% -$254K 0.31% 73
2017
Q1
$11M Sell
88,098
-5,691
-6% -$681K 0.32% 71
2016
Q4
$10.9M Buy
93,789
+8,022
+9% +$893K 0.33% 69
2016
Q3
$8.96M Buy
85,767
+1,445
+2% +$156K 0.29% 77
2016
Q2
$8.32M Buy
84,322
+16,266
+24% +$1.68M 0.27% 80
2016
Q1
$6.81M Buy
68,056
+21,873
+47% +$2.25M 0.24% 79
2015
Q4
$5.53M Sell
46,183
-1,565
-3% -$181K 0.19% 93
2015
Q3
$5.16M Sell
47,748
-2,377
-5% -$295K 0.19% 95
2015
Q2
$5.8M Sell
50,125
-579
-1% -$66.2K 0.19% 92
2015
Q1
$5.84M Sell
50,704
-2,858
-5% -$342K 0.2% 89
2014
Q4
$5.99M Sell
53,562
-5,265
-9% -$555K 0.2% 88
2014
Q3
$5.58M Sell
58,827
-4,831
-8% -$436K 0.19% 91
2014
Q2
$5.47M Sell
63,658
-4,576
-7% -$348K 0.2% 82
2014
Q1
$4.76M Sell
68,234
-11,780
-15% -$933K 0.17% 88
2013
Q4
$6.76M Sell
80,014
-13,998
-15% -$1.11M 0.25% 75
2013
Q3
$7.25M Sell
94,012
-25,594
-21% -$1.79M 0.29% 67
2013
Q2
$7M Buy
+119,606
New +$7.2M 0.29% 68

Other funds holding CELG

Johnson Investment Counsel's CELG Position: Q4 2019 in Review

Johnson Investment Counsel sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,930 shares — an estimated $1.68M sold.

Johnson Investment Counsel first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $12.6M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Johnson Investment Counsel reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Johnson Investment Counsel sold 16,930 Celgene Corp shares in Q4 2019, an estimated $1.68M.
  • Johnson Investment Counsel first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Johnson Investment Counsel's Celgene Corp position peaked at $12.6M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Johnson Investment Counsel's 13F filing for Q4 2019, filed 13 Feb 2020.